(Nano) platforms in bladder cancer therapy: Challenges and opportunities
M Ashrafizadeh, A Zarrabi… - Bioengineering & …, 2023 - Wiley Online Library
Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …
particular, bladder cancer severely threatens human health due to its aggressive and …
Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials
Context The role of adjuvant chemotherapy remains poorly defined for the management of
muscle-invasive bladder cancer (MIBC). The last meta-analysis evaluating adjuvant …
muscle-invasive bladder cancer (MIBC). The last meta-analysis evaluating adjuvant …
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Cytotoxic chemotherapy is effective in debulking tumour masses initially; however, in some
patients tumours become progressively unresponsive after multiple treatment cycles …
patients tumours become progressively unresponsive after multiple treatment cycles …
Bladder cancer treatment response assessment in CT using radiomics with deep-learning
Cross-sectional X-ray imaging has become the standard for staging most solid organ
malignancies. However, for some malignancies such as urinary bladder cancer, the ability to …
malignancies. However, for some malignancies such as urinary bladder cancer, the ability to …
Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature
Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
Histological and molecular analyses of urothelial carcinoma often reveal intratumoural and
intertumoural heterogeneity at the genomic, transcriptional and cellular levels. Despite the …
intertumoural heterogeneity at the genomic, transcriptional and cellular levels. Despite the …
[HTML][HTML] Role of immunotherapy in bladder cancer
LP Rhea, S Mendez-Marti, D Kim… - Cancer Treatment and …, 2021 - Elsevier
The role of immunotherapy in bladder urothelial cancers is rapidly expanding. Since the
initial second-line therapy approval for patients who fail prior platinum-based chemotherapy …
initial second-line therapy approval for patients who fail prior platinum-based chemotherapy …
Aberrant expression of microRNAs in bladder cancer
H Yoshino, N Seki, T Itesako, T Chiyomaru… - Nature Reviews …, 2013 - nature.com
MicroRNAs (miRNAs), a class of small noncoding RNAs, regulate protein-coding gene
expression by repressing translation or cleaving RNA transcripts in a sequence-specific …
expression by repressing translation or cleaving RNA transcripts in a sequence-specific …
Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review
Bladder cancer is the most common malignancy of the urinary tract, presents the highest
recurrence rate among solid tumors and is the second leading cause of death in …
recurrence rate among solid tumors and is the second leading cause of death in …
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
K Miyamoto, N Seki, R Matsushita, M Yonemori… - British journal of …, 2016 - nature.com
Background: Previous studies have revealed that miR-26a-5p and miR-26b-5p act as
tumour suppressors in various types of cancer tissues. Here, we aimed to investigate the …
tumour suppressors in various types of cancer tissues. Here, we aimed to investigate the …